Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma

The clinical implications of medulloblastoma subgroups

(2012) Paul A. Northcott et al.   Nature Reviews Neurology

Risk-adapted chemotherapy in childhood medulloblastoma

(2011) Ali Varan   Expert Review of Anticancer Therapy

Childhood medulloblastoma

(2010) Maura Massimino et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Double High-dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Primary Disseminated Medulloblastoma

(2010) Yasuo Aihara et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

(2009) Katherine K. Matthay et al.   JOURNAL OF CLINICAL ONCOLOGY

Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings

(2009) Lisa Diller et al.   JOURNAL OF CLINICAL ONCOLOGY

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors

(2009) Amy Rosenfeld et al.   JOURNAL OF NEURO-ONCOLOGY

Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors

(2008) A Marachelian et al.   BONE MARROW TRANSPLANTATION

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience

(2007) Jason Fangusaro et al.   PEDIATRIC BLOOD & CANCER